ATE132875T1 - Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung - Google Patents

Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung

Info

Publication number
ATE132875T1
ATE132875T1 AT91305493T AT91305493T ATE132875T1 AT E132875 T1 ATE132875 T1 AT E132875T1 AT 91305493 T AT91305493 T AT 91305493T AT 91305493 T AT91305493 T AT 91305493T AT E132875 T1 ATE132875 T1 AT E132875T1
Authority
AT
Austria
Prior art keywords
protein
cells
hiv activity
producing cell
cell protein
Prior art date
Application number
AT91305493T
Other languages
English (en)
Inventor
Meihan Nonoyama
Akiko Tanaka
Partrick K Lai
Original Assignee
Tampa Bay Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tampa Bay Research Inst filed Critical Tampa Bay Research Inst
Application granted granted Critical
Publication of ATE132875T1 publication Critical patent/ATE132875T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91305493T 1990-06-20 1991-06-18 Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung ATE132875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54097390A 1990-06-20 1990-06-20
US07/659,564 US5346988A (en) 1990-06-20 1991-02-22 Process for obtaining cellular protein having anti-HIV activity

Publications (1)

Publication Number Publication Date
ATE132875T1 true ATE132875T1 (de) 1996-01-15

Family

ID=27066570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91305493T ATE132875T1 (de) 1990-06-20 1991-06-18 Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung

Country Status (5)

Country Link
US (2) US5346988A (de)
EP (1) EP0462792B1 (de)
AT (1) ATE132875T1 (de)
DE (1) DE69116240T2 (de)
ES (1) ES2082140T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346988A (en) * 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
WO1996004303A1 (en) * 1994-08-04 1996-02-15 Tampa Bay Research Institute Protein having anti-retrovirus activity and method for obtaining it
US5643881A (en) * 1994-08-04 1997-07-01 Tampa Bay Research Institute Protein having anti-HIV activity and method for obtaining it
RU2172322C1 (ru) 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
EP1716513A4 (de) * 2003-12-29 2011-06-08 Nokia Corp Vorrichtung und assoziiertes verfahren zur erkennung von paketen
RU2276988C2 (ru) * 2004-01-15 2006-05-27 Сергей Иванович Черныш Антивирусное вещество

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683199A (en) * 1983-01-31 1987-07-28 Sloan-Kettering Institute For Cancer Research Interleukin-2 dependent cytotoxic T-cell clones
JPS59181293A (ja) * 1983-03-31 1984-10-15 Kyowa Hakko Kogyo Co Ltd 新規生理活性蛋白性物質
JPS6062997A (ja) * 1983-09-17 1985-04-11 Mochida Pharmaceut Co Ltd インタ−フエロンの生産方法
EP0193032A3 (de) * 1985-02-13 1988-04-06 Gesellschaft für Biotechnologische Forschung mbH (GBF) Zusammensetzung umfassend oder enthaltend Cytokin, Herstellungsverfahren, DNA-Sequenz und deren Verwendung
US5039794A (en) * 1986-09-19 1991-08-13 Otsuka Pharmaceutical Co., Ltd. Tumor egress factor and processes for producing the same
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
JPS6490199A (en) * 1987-09-30 1989-04-06 Hiromi Fujiwara T cell growth factor derived from thymic interstitial cell and production thereof
US5346988A (en) * 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
US5236829A (en) * 1990-12-10 1993-08-17 The Johns Hopkins University Method of producing monokine induced by gamma interferon

Also Published As

Publication number Publication date
ES2082140T3 (es) 1996-03-16
EP0462792A2 (de) 1991-12-27
EP0462792B1 (de) 1996-01-10
DE69116240T2 (de) 1996-05-23
US5346988A (en) 1994-09-13
DE69116240D1 (de) 1996-02-22
EP0462792A3 (en) 1992-05-27
US5480782A (en) 1996-01-02

Similar Documents

Publication Publication Date Title
ATE253112T1 (de) Menschliche hematopoietische stammzellen
ATE406435T1 (de) Methoden zur züchtung von tierzellen
ATE209679T1 (de) Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen
JPS6133593B2 (de)
AT380272B (de) Verfahren zur herstellung von mikroorganismen
ATE46358T1 (de) Verfahren zur zuechtung von lyophilisierten mikroorganismen.
DE69123944D1 (de) Verfahren zur Herstellung von Hydrogengas unter Verwendung von Mikroorganismen
ATE75775T1 (de) Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.
ATE2442T1 (de) Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung.
DE69116240D1 (de) Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung
ATE220714T1 (de) Verfahren zur herstellung von proteinen
EP0380692A4 (en) Plant tissue culture process
ATE82985T1 (de) Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
DE3687699D1 (de) Verfahren und vorrichtung zum kultivieren von zellen.
DE68907166D1 (de) Verfahren zur herstellung von menschlichem lysozym.
EP0310056A3 (de) T-Zellen-Wachstumsfaktor aus Thymusdrüsen-Stroma und Verfahren zu seiner Herstellung
DE3875752D1 (de) Verfahren zur herstellung von aktivierten toetenden zellen.
DE3582368D1 (de) Verfahren zur herstellung von epoxyden mittels mikroorganismen.
ATA223579A (de) Verfahren zur herstellung eines aggregates von bakterienzellen
DE69104037D1 (de) Verfahren zur darstellung von hochreinem tetrahydrofuran.
ATE112170T1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
DE3677421D1 (de) Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.
ATA370885A (de) Verfahren zur herstellung neuer mikroorganismen zur produktion von hybriden human-leukozyten-interferonen
ATE2339T1 (de) Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung.
DE69004964D1 (de) Zellenzuchtverfahren für die produktion von aktiviertem protein-c.